跳至主要内容
临床试验/NCT00177268
NCT00177268招募中不适用

Peripheral Blood, Urine and Skin Sample Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

University of Pittsburgh1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2004年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
200
试验地点
1
主要终点
Proteomics of Cutaneous T-cell lymphoma

研究概览

简要总结

This is a tissue, urine, and blood banking protocol for cutaneous t-cell lymphoma (CTCL), eczema, and atopic dermatitis patients for current and future research.

详细描述

The purpose of this study is to provide a central mechanism for monitoring access to peripheral blood, urine, and skin specimens obtained from CTCL, eczema, and atopic dermatitis patients to monitor:

  • immunologic assays/flow cytometry
  • tumor progression/regression
  • genomic studies
  • proteomic studies
  • others germane to the advancement of CTCL treatment

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 or older
  • able and willing to provide informed consent
  • diagnosed with CTCL
  • diagnosed with either atopic dermatitis or eczema

排除标准

  • Lack of CTCL, atopic dermatitis, or eczema diagnosis in medical record

结局指标

主要结局

Proteomics of Cutaneous T-cell lymphoma

时间窗: Ongoing

Proteomic variables will be measured in blood and tissue of consented CTCL patients.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Oleg E. Akilov, MD, PhD

Assistant Professor of Dermatology

University of Pittsburgh

研究点 (1)

Loading locations...

相似试验